Sunday, September 02, 2012 6:50:08 PM
I really don't understand what your trying to get at here. IMO, this looks like very good results for a phase 2 trial. The company must feel the same way as they already started designing their phase 3 trial. Help me out. Are you saying that they should do the opposite and kill bavi based on the phase 2 results? Maybe your saying that the FDA isn't going to approve a phase 3 trial because of the phase 2 results? Please be more specific.
TIA,
mojo
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
